Titre
Production of antibody to hepatitis A virus and hepatitis B surface antigen measured after combined hepatitis A/hepatitis B vaccination in 242 adult volunteers
Type
article
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Périodique
Auteur(s)
Reutter, J.
Auteure/Auteur
Bart, P. A.
Auteure/Auteur
Francioli, P.
Auteure/Auteur
Safary, A.
Auteure/Auteur
Frei, P. C.
Auteure/Auteur
Liens vers les personnes
Liens vers les unités
ISSN
1352-0504
Statut éditorial
Publié
Date de publication
1998-05
Volume
5
Numéro
3
Première page
205
Dernière page/numéro d’article
11
Notes
Clinical Trial
Controlled Clinical Trial
Journal Article --- Old month value: May
Controlled Clinical Trial
Journal Article --- Old month value: May
Résumé
Two batches of a new hepatitis A/hepatitis B combined vaccine were tested in 242 healthy students. Three injections, given at 0, 1 and 6 months, produced seroconversion rates and hepatitis A virus (HAV) and hepatitis B surface antigen (HBsAg) antibody levels comparable to those reported after administration of separate monocomponent vaccines. The vaccine proved to be safe and well-tolerated. Influence of host factors, such as elevated body mass index or gender, were investigated and proven to be of little influence on the immunoresponse.
Sujets
PID Serval
serval:BIB_B5FDCFC5499D
PMID
Date de création
2008-01-25T16:07:35.662Z
Date de création dans IRIS
2025-05-21T04:59:07Z